Navigation Links
Frutarom Gewurzmuller and Blessing Biotech Acquisition Conference Call Scheduled for Monday, October 15, 2007
Date:10/15/2007

presence in its key target markets. Frutarom's broad product portfolio comprises over 15,000 products, focusing on flavors and natural fine ingredients. Frutarom markets and sells its products to over 5,000 customers in more than 120 countries, operating production facilities in Europe, North America, Israel and Asia. Frutarom has 22 research and development laboratories, and sells and markets its products principally through its 45 sales and marketing offices. Frutarom is listed on the London Stock Exchange and the Tel Aviv Stock Exchange.

For more information please visit our web site: http://www.frutarom.com.

Company Contact

Ori Yehudai, President & CEO

Frutarom Ltd.

Tel: +972-4-846-2401

E-mail: oyehudai@frutarom.com


'/>"/>
SOURCE Frutarom Industries Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cell Phones and pagers are mixed blessing
2. Nature’s Bounty ,Seaweed, Becomes A Blessing For Diabetes Patient
3. New Home New Blessings
4. Alcoholics Anonymous: A Blessing For The Addicted
5. The Blessing of Good Mental Health Begins with Breast Milk, Says a Study
6. Pneumonia Vaccine is a Blessing, Study Shows
7. Biotechnology industry expected to grow into a three billion dollar industry by 2002
8. Biotechnology on the lead
9. Panacea Biotech To Market Anthrax Vaccine
10. Commercialization of Biotech Discoveries, An Encouragement For Researchers
11. Biotech drug causing anemia-EPREX
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 3Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 4Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 5Health News:The Breema Center Presents a Yearlong Campaign to Transform Stress into Harmony in 2010 and Beyond 2Health News:Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions 2Health News:Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions 3Health News:Frost & Sullivan to Hold Web Conference on Integrated Hospital Pharmacy Information Systems - How to Maneuver towards Growth Potential 2Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 2Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 3
Other Medicine News:Health News:Digirad Corporation to Release Third Quarter, Nine-Month Financial Results on October 25, 2007 2Health News:Data Dialog Marketing Expands Sales Management Team 2Health News:Data Dialog Marketing Expands Sales Management Team 3Health News:Media availability: low-fat dietary pattern may lower risk of ovarian cancer 2Health News:Media availability: low-fat dietary pattern may lower risk of ovarian cancer 3Health News:Governor Schwarzenegger's Mandatory Purchase of Private Health Insurance Doesn't Add Up for the Middle-Class, Says FTCR 2Health News:Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco 2Health News:Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco 3Health News:Two Million Californians Say 'Yes!' to Organ and Tissue Donation 2Health News:Two Million Californians Say 'Yes!' to Organ and Tissue Donation 3Health News:Two Million Californians Say 'Yes!' to Organ and Tissue Donation 4
Breaking Medicine Technology:Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 2Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 4Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 5At Nearly $120 Million, The Hepatitis C Drug Market in Brazil is Among the Largest Emerging Pharmaceutical Markets for the Disease 2Study shows that elderly women sleep better than they think men sleep worse 58615 1Study shows that elderly women sleep better than they think men sleep worse 58615 2Platelet rich plasma 3A Does it work 3F 58610 1Platelet rich plasma 3A Does it work 3F 58610 2Platelet rich plasma 3A Does it work 3F 58610 3Announcing the new Journal of Integrated Pest Management 10201 1Announcing the new Journal of Integrated Pest Management 10201 2